Congress returns next week and Republicans will pick-up their efforts to pass a reconciliation bill to extend the 2017 Tax ...

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.